Elevation of plasma phenytoin by viloxazine in epileptic patients: a clinically significant drug interaction.
The effect of viloxazine (150-300 mg daily for 21 days) on plasma phenytoin levels at steady state was examined in 10 epileptic patients stabilised on a fixed phenytoin dosage. After starting viloxazine treatment, plasma phenytoin concentrations increased by 37% on average (range 7-94%) from a mean...
Tallennettuna:
| Julkaisussa: | J Neurol Neurosurg Psychiatry |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
1992
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC488975/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1538217/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.55.2.126 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
